S 3220
118th Congress
Senate
Health
A bill to expand the tropical disease product priority review voucher program to encourage prevention and treatment of coccidioidomycosis.
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 2, 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Nov 2, 2023
Introduced in Senate
Plain-English summary
This bill expands the priority-review voucher program for tropical diseases to include coccidioidomycosis (also known as Valley fever). A voucher entitles the holder to have a future new drug or biological product application acted upon by the Food and Drug Administration within six months.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Committees of jurisdiction
1